Xiaobing Qing
Xiaobing Qing
Leibniz Institute on Aging - Fritz Lipmann Institute
Bestätigte E-Mail-Adresse bei leibniz-fli.de
Titel
Zitiert von
Zitiert von
Jahr
A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts
R Li, J Liang, S Ni, T Zhou, X Qing, H Li, W He, J Chen, F Li, Q Zhuang, ...
Cell stem cell 7 (1), 51-63, 2010
11762010
Modeling Parkinson’s disease in midbrain-like organoids
LM Smits, L Reinhardt, P Reinhardt, M Glatza, AS Monzel, N Stanslowsky, ...
NPJ Parkinson's disease 5 (1), 1-8, 2019
1042019
3D cultures of Parkinson's disease‐specific dopaminergic neurons for high content phenotyping and drug testing
S Bolognin, M Fossépré, X Qing, J Jarazo, J Ščančar, EL Moreno, ...
Advanced Science 6 (1), 1800927, 2019
542019
FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson's disease modeling
J Arias-Fuenzalida, J Jarazo, X Qing, J Walter, G Gomez-Giro, SL Nickels, ...
Stem Cell Reports 9 (5), 1423-1431, 2017
532017
Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease
AD Spathis, X Asvos, D Ziavra, T Karampelas, S Topouzis, Z Cournia, ...
Proceedings of the National Academy of Sciences 114 (15), 3999-4004, 2017
482017
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
X Qing, J Walter, J Jarazo, J Arias-Fuenzalida, AL Hillje, JC Schwamborn
Stem Cell Research 24, 44-50, 2017
462017
Neural stem cells of Parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality
J Walter, S Bolognin, PMA Antony, SL Nickels, SK Poovathingal, ...
Stem cell reports 12 (5), 878-889, 2019
442019
Class IIa histone deacetylases and myocyte enhancer factor 2 proteins regulate the mesenchymal-to-epithelial transition of somatic cell reprogramming
Q Zhuang, X Qing, Y Ying, H Wu, C Benda, J Lin, Z Huang, L Liu, Y Xu, ...
Journal of Biological Chemistry 288 (17), 12022-12031, 2013
202013
Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients
SL Nickels, J Walter, S Bolognin, D Gérard, C Jaeger, X Qing, J Tisserand, ...
Parkinsonism & related disorders 67, 48-55, 2019
102019
Modeling Parkinson’s disease in midbrain-like organoids. NPJ Park Dis 5: 5
LM Smits, L Reinhardt, P Reinhardt, M Glatza, AS Monzel, N Stanslowsky, ...
72019
Parkinson’s disease phenotypes in patient specific brain organoids are improved by HP-β-CD treatment
J Jarazo, K Barmpa, I Rosety, LM Smits, J Arias-Fuenzalida, J Walter, ...
Biorxiv, 813089, 2019
62019
Guidelines for fluorescent guided biallelic HDR targeting selection with PiggyBac system removal for gene editing
J Jarazo, X Qing, JC Schwamborn
Frontiers in genetics 10, 190, 2019
42019
Nuclear-cytoplasmic shuttling of class IIa histone deacetylases regulates somatic cell reprogramming
Z Luo, X Qing, C Benda, Z Huang, M Zhang, Y Huang, H Zhang, L Wang, ...
Cell Regeneration 8 (1), 21-29, 2019
22019
Means and methods for selecting transformed cells
JA Fuenzalida, J Jarazo, J Schwamborn, X Qing
US Patent App. 16/073,005, 2020
2020
Parkinson's disease associated embryonic neurodevelopmental phenotypes
J Walter, S Nickels, J Arias, X Qing, J Jarazo, F Noel, K Tronstad, ...
HUMAN GENE THERAPY 27 (11), A80-A80, 2016
2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15